March 25, 2010 – The FDA this week granted permission for a conditional investigational device exemption (IDE) to evaluate the safety and efficacy of a transcatheter plug to seal the left atrial appendage (LAA). The appendage is frequently the source of stroke-causing clots in atrial fibrillation patients.
